Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Post by SanFrancisco99on Jul 27, 2016 11:07am
140 Views
Post# 25088395

An Invitation To Comment

An Invitation To CommentA group of shareholders on Agoracom have come up with a list of questions that we would like to send to management in advance of the AGM in order to seek information for a number of outstanding items that have not been fully addressed yet by management.

The write-up of that list is an ongoing effort still in draft form.  I am posting here to let readers of Stockhouse know about this development and to seek your input and comments, as this write-up is still a draft.

Below is a web address where the current version of the list resides.  It is being worked on in the "Off Topic Forum" within Agoracom.

We welcome any constructive imput and additional questions to add to the list.

Thank you,

SF
===================

https://agoracom.com/ir/Resverlogix/forums/off-topic/topics/671324-near-final-draft-of-checklist-for-management/messages/2102838#message
Bullboard Posts